Engerix-B

hepatitis B virus

Pharma

FDA approves VBI's PreHevbrio just as HBV market is set to grow

With an FDA approval for its hepatitis B shot, PreHevbrio, VBI Vaccines is poised to take advantage of what figures to be a growing market.

Kevin Dunleavy Dec 1, 2021 10:34am

dynavax

Efficacy, convenient dosage give Dynavax's Heplisav-B an edge

Nov 5, 2021 7:00am

newspaper

Heplisav-B; Janssen and more—News of Note

Feb 27, 2019 9:14am

vaccine

VBI’s hep B shot in pivotal trial against GSK's Engerix-B

Dec 19, 2017 3:48pm